4.8 Article

SUMO2/3 modification of cyclin E contributes to the control of replication origin firing

Journal

NATURE COMMUNICATIONS
Volume 4, Issue -, Pages -

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/ncomms2875

Keywords

-

Funding

  1. INSERM
  2. Region Languedoc Roussillon
  3. ARC

Ask authors/readers for more resources

The small ubiquitin-like modifier (SUMO) pathway is essential for the maintenance of genome stability. We investigated its possible involvement in the control of DNA replication during S phase by using the Xenopus cell-free system. Here we show that the SUMO pathway is critical to limit the number and, thus, the density of replication origins that are activated in early S phase. We identified cyclin E, which regulates cyclin-dependent kinase 2 (Cdk2) to trigger origin firing, as an S-phase substrate of this pathway. We show that cyclin E is dynamically and highly conjugated to SUMO2/3 on chromatin, independently of Cdk2 activity and origin activation. Moreover, cyclin E is the predominant SUMO2/3 target on chromatin in early S phase, as cyclin E depletion abolishes, while its readdition restores, the SUMO2/3 signal. Together, our data indicate that cyclin E SUMOylation is important for controlling origin firing once the cyclin E-Cdk2 complex is recruited onto replication origins.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Biochemistry & Molecular Biology

The C-terminal segment of Leishmania major HslU: Toward potential inhibitors of LmHslVU activity

Priyanka Singh, Krishnananda Samanta, Ndeye Mathy Kebe, Gregory Michel, Baptiste Legrand, Vera E. Sitnikova, Andrey Kajava, Michel Pages, Patrick Bastien, Christelle Pomares, Olivier Coux, Jean-Francois Hernandez

Summary: Developing less toxic and more efficient treatments for leishmaniases and trypanosomiases is urgent. By targeting the parasite mitochondrial HslVU protease, which is essential for growth and has no analogue in the human host, we have developed compounds potentially inhibiting the complex assembly. Through the study of the structure-activity relationships, we have obtained more potent analogues. Additionally, conjugates of the analogues and a mitochondrial penetrating peptide have been found to penetrate into the parasite and inhibit its growth without toxicity to human cells.

BIOORGANIC CHEMISTRY (2022)

Article Biochemistry & Molecular Biology

PA28γ-20S proteasome is a proteolytic complex committed to degrade unfolded proteins

Jean-Yves Alejandro Frayssinhes, Fulvia Cerruti, Justine Laulin, Angela Cattaneo, Angela Bachi, Sebastien Apcher, Olivier Coux, Paolo Cascio

Summary: PA28 gamma is a nuclear activator of the 20S proteasome, stimulating the degradation of unfolded proteins; it increases breakdown rates of these proteins by 20S proteasomes while decreasing the variability of peptides potentially suitable for MHC class I antigen presentation.

CELLULAR AND MOLECULAR LIFE SCIENCES (2022)

Article Hematology

The NADPH oxidase NOX2 is a marker of adverse prognosis involved in chemoresistance of acute myeloid leukemias

Rosa Paolillo, Mathias Boulanger, Pierre Gatel, Ludovic Gabellier, Marion De Toledo, Denis Tempe, Rawan Hallal, Dana Akl, Jerome Moreaux, Hayeon Baik, Elise Gueret, Christian Recher, Jean-Emmanuel Sarry, Guillaume Cartron, Marc Piechaczyk, Guillaume Bossis

Summary: Resistance to chemotherapeutic drugs is a major cause of treatment failure in acute myeloid leukemias (AML). This study found that upregulation of NOX2 NADPH oxidase subunit genes is associated with increased reactive oxygen species production and resistance to daunorubicin in AML cells. High expression of these genes is also a marker of adverse prognosis in AML patients.

HAEMATOLOGICA (2022)

Article Chemistry, Multidisciplinary

Intra-articular delivery of full-length antibodies through the use of an in situ forming depot

Alexis Fayd'herbe De Maudave, Wilhem Leconet, Karine Toupet, Michael Constantinides, Guillaume Bossis, Marion de Toledo, Jerome Vialaret, Christophe Hirtz, Adolfo Lopez-Noriega, Christian Jorgensen, Daniele Noel, Pascale Louis-Plence, Sylvestre Grizot, Martin Villalba

Summary: Monoclonal antibodies have high therapeutic potential for cancer or autoimmune diseases, but intravenous administration can lead to off-target effects. Utilizing a local controlled-delivery approach with in situ forming depot technology can help address this issue.

JOURNAL OF CONTROLLED RELEASE (2022)

Article Genetics & Heredity

Activation of the ubiquitin-proteasome system contributes to oculopharyngeal muscular dystrophy through muscle atrophy

Cecile Ribot, Cedric Soler, Aymeric Chartier, Sandy Al Hayek, Rima Nait-Saidi, Nicolas Barbezier, Olivier Coux, Martine Simonelig

Summary: Oculopharyngeal muscular dystrophy (OPMD) is a late-onset disorder characterized by progressive weakness and degeneration of specific muscles. Previous studies have shown that the ubiquitin-proteasome system (UPS) is deregulated in OPMD, contributing to the disease pathogenesis. In this Drosophila model of OPMD, increased UPS activity leads to muscle protein degradation and atrophy. Inhibitors of proteasome activity, such as MG132, show potential as a pharmacological approach for OPMD treatment, improving muscle function. This study highlights the importance of UPS deregulation in OPMD and suggests proteasome inhibitors as potential therapeutic options.

PLOS GENETICS (2022)

Article Oncology

Constitutive Activation of p62/Sequestosome-1-Mediated Proteaphagy Regulates Proteolysis and Impairs Cell Death in Bortezomib-Resistant Mantle Cell Lymphoma

Gregoire Quinet, Wendy Xolalpa, Diana Reyes-Garau, Nuria Profitos-Peleja, Mikel Azkargorta, Laurie Ceccato, Maria Gonzalez-Santamarta, Maria Marsal, Jordi Andilla, Fabienne Aillet, Francesc Bosch, Felix Elortza, Pablo Loza-Alvarez, Brigitte Sola, Olivier Coux, Rune Matthiesen, Gael Roue, Manuel S. Rodriguez

Summary: The research identified an enrichment of autophagy-lysosome system (ALS) components in bortezomib (BTZ)-resistant cells in mantle cell lymphoma (MCL) patients. By blocking proteaphagy, the normal proteasomal activity was reactivated and the BTZ antitumor effect was restored in vitro and in vivo models of BTZ resistance. These findings suggest a proteolytic switch from the ubiquitin-proteasome system (UPS) to ALS in B-cell lymphoma refractory to proteasome inhibition, opening up new therapeutic avenues for treatment-resistant tumors.

CANCERS (2022)

Review Pharmacology & Pharmacy

RNA-Based Strategies for Cell Reprogramming toward Pluripotency

Anaelle Bailly, Ollivier Milhavet, Jean-Marc Lemaitre

Summary: Cell reprogramming techniques, including RNA-based strategies, have shown great potential in treating various diseases and improving healthspan and longevity.

PHARMACEUTICS (2022)

Article Biochemistry & Molecular Biology

Trim39 regulates neuronal apoptosis by acting as a SUMO-targeted E3 ubiquitin-ligase for the transcription factor NFATc3

Meenakshi Basu Shrivastava, Barbara Mojsa, Stephan Mora, Ian Robbins, Guillaume Bossis, Irena Lassot, Solange Desagher

Summary: NFATc3, a member of the NFAT family of transcription factors, plays a critical role in neuronal apoptosis. This study identifies Trim39 as an E3 ubiquitin-ligase that regulates the stability and activity of NFATc3 by binding and ubiquitinating it. Trim17 is found to inhibit Trim39-mediated ubiquitination of NFATc3 by reducing the E3 ligase activity and interaction between Trim39 and NFATc3. Additionally, Trim39 is identified as a new SUMO-targeted E3 ubiquitin-ligase. These findings demonstrate the role of Trim39 as a STUbL for NFATc3 in modulating neuronal apoptosis.

CELL DEATH AND DIFFERENTIATION (2022)

Article Cell Biology

Bidirectional regulation between AP-1 and SUMOylation pathway genes modulates inflammatory signaling during Salmonella infection

Pharvendra Kumar, Amarendranath Soory, Salman Ahmad Mustfa, Dipanka Tanu Sarmah, Himadri Devvanshi, Samrat Chatterjee, Guillaume Bossis, Girish S. Ratnaparkhi, Chittur Srikanth

Summary: This study investigated the regulation of SUMO pathway genes during Salmonella Typhimurium (STm) infection. It was found that c-Fos, a component of AP-1, directly binds to the promoters of UBC9 and PIAS1 to regulate their expression. Perturbation of c-Fos causes changes in the expression of UBC9 and PIAS1, and SUMOylation-deficient c-Fos leads to uncontrolled activation of target genes, favoring STm replication.

JOURNAL OF CELL SCIENCE (2022)

Article Multidisciplinary Sciences

TRIM28-dependent SUMOylation protects the adult ovary from activation of the testicular pathway

Moira Rossitto, Stephanie Dejardin, Chris M. Rands, Stephanie Le Gras, Roberta Migale, Mahmoud-Reza Rafiee, Yasmine Neirijnck, Alain Pruvost, Anvi Laetitia Nguyen, Guillaume Bossis, Florence Cammas, Lionel Le Gallic, Dagmar Wilhelm, Robin Lovell-Badge, Brigitte Boizet-Bonhoure, Serge Nef, Francis Poulat

Summary: Gonadal fate in mammals is determined during embryogenesis and is actively maintained in adulthood. This study shows that E3-SUMO ligase activity of TRIM28 is required for ovarian identity maintenance and testicular-specific gene repression in mouse adult ovary; in its absence, ovarian granulosa cells transdifferentiate to Sertoli cells.

NATURE COMMUNICATIONS (2022)

Article Multidisciplinary Sciences

Loss of SUMO-specific protease 2 causes isolated glucocorticoid deficiency by blocking adrenal cortex zonal transdifferentiation in mice

Damien Dufour, Typhanie Dumontet, Isabelle Sahut-Barnola, Aude Carusi, Meline Onzon, Eric Pussard, James Jr Wilmouth, Julie Olabe, Cecily Lucas, Adrien Levasseur, Christelle Damon-Soubeyrand, Jean-Christophe Pointud, Florence Roucher-Boulez, Igor Tauveron, Guillaume Bossis, Edward T. Yeh, David T. Breault, Pierre Val, Anne-Marie Lefrancois-Martinez, Antoine Martinez

Summary: SUMOylation is a dynamic posttranslational modification that plays a critical role in adrenal homeostasis and stress responsiveness. Disruption of SENP2 activity in steroidogenic cells leads to specific hypoplasia of the zona fasciculata, a blunted response to ACTH, and isolated glucocorticoid deficiency. The mechanism involves a shift in the balance between ACTH/PKA and WNT/beta-catenin signaling, resulting in repression of PKA activity and ectopic activation of beta-catenin.

NATURE COMMUNICATIONS (2022)

Article Biochemistry & Molecular Biology

DeSUMOylation of chromatin-bound proteins limits the rapid transcriptional reprogramming induced by daunorubicin in acute myeloid leukemias

Mathias Boulanger, Mays Aqrouq, Denis Tempe, Chamseddine Kifagi, Marko Ristic, Dana Akl, Rawan Hallal, Aude Carusi, Ludovic Gabellier, Marion de Toledo, Jon-Otti Sigurdsson, Tony Kaoma, Charlotte Andrieu-Soler, Thierry Forne, Eric Soler, Yosr Hicheri, Elise Gueret, Laurent Vallar, Jesper Olsen, Guillaume Cartron, Marc Piechaczyk, Guillaume Bossis

Summary: Daunorubicin (DNR), a main drug used for treating Acute Myeloid Leukemia (AML), induces rapid and broad transcriptional changes in AML cells within 3 hours. These changes involve genes controlling cell proliferation, death, inflammation, and immunity. DNR also causes deSUMOylation of chromatin proteins, primarily transcription factors, co-regulators, and chromatin organizers, and this deSUMOylation is crucial for the transcriptional reprogramming. Inhibition of SUMOylation with ML-792 prevents the chromatin loop reconfiguration and interaction between CTCF and SUMO-bound NFKB2 promoter.

NUCLEIC ACIDS RESEARCH (2023)

Article Biochemistry & Molecular Biology

Senescence-Driven Inflammatory and Trophic Microenvironment Imprints Mesenchymal Stromal/Stem Cells in Osteoarthritic Patients

Giuseppe Fusi, Michael Constantinides, Christina Fissoun, Lydiane Pichard, Yves-Marie Pers, Rosanna Ferreira-Lopez, Veronique Pantesco, Christophe Poulet, Olivier Malaise, Dominique De Seny, Jean-Marc Lemaitre, Christian Jorgensen, Jean-Marc Brondello

Summary: Senescent cells play a role in tissue degeneration and contribute to age-related diseases such as osteoarthritis. This study investigates how the senescence-driven microenvironment affects the fate of MSCs and contributes to the progression of osteoarthritis.

BIOMEDICINES (2023)

Article Chemistry, Multidisciplinary

Discovery and Mechanism of Action of Small Molecule Inhibitors of Ceramidases

Robert D. Healey, Essa M. Saied, Xiaojing Cong, Gergely Karsai, Ludovic Gabellier, Julie Saint-Paul, Elise Del Nero, Sylvain Jeannot, Marion Drapeau, Simon Fontanel, Damien Maurel, Shibom Basu, Cedric Leyrat, Jerome Golebiowski, Guillaume Bossis, Cherine Bechara, Thorsten Hornemann, Christoph Arenz, Sebastien Granier

Summary: Sphingolipid metabolism is tightly regulated by enzymes, with recent attention on the discovery and mechanism of action of the first drug-like inhibitors of alkaline ceramidase 3 (ACER3). This discovery opens up a new paradigm for targeting ACER3 in drug discovery efforts.

ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2022)

Article Chemistry, Multidisciplinary

Discovery and Mechanism of Action of Small Molecule Inhibitors of Ceramidases

Robert D. Healey, Essa M. Saied, Xiaojing Cong, Gergely Karsai, Ludovic Gabellier, Julie Saint-Paul, Elise Del Nero, Sylvain Jeannot, Marion Drapeau, Simon Fontanel, Damien Maurel, Shibom Basu, Cedric Leyrat, Jerome Golebiowski, Guillaume Bossis, Cherine Bechara, Thorsten Hornemann, Christoph Arenz, Sebastien Granier

Summary: This study presents the discovery and mechanism of action of the first drug-like inhibitors of alkaline ceramidase 3 (ACER3), as well as the characterization of enzyme:inhibitor interactions using mass spectrometry and MD simulations. The use of novel fluorescent ceramide substrates enables screening of large compound libraries, offering a new paradigm for inhibition of lipid metabolizing enzymes with non-lipidic small molecules. The findings lay the groundwork for targeting ACER3 in drug discovery efforts.

ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2022)

No Data Available